Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Titan Pharma (TTNP)

Titan Pharma (TTNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,132
  • Shares Outstanding, K 1,330
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,710 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 1.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.20
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.95
  • Most Recent Earnings $-0.65 on 08/14/25
  • Next Earnings Date 08/21/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.58 +28.95%
on 09/02/25
4.80 -3.96%
on 10/01/25
+0.65 (+16.41%)
since 08/29/25
3-Month
3.58 +28.95%
on 09/02/25
5.35 -13.83%
on 07/24/25
+0.35 (+8.21%)
since 07/01/25
52-Week
3.03 +52.15%
on 01/02/25
5.76 -19.97%
on 05/09/25
-0.59 (-11.43%)
since 10/01/24

Most Recent Stories

More News
Titan Pharmaceuticals Undergoes Leadership Restructuring

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

TTNP : 4.61 (-3.76%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 4.61 (-3.76%)
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Titan Pharmaceuticals , Inc....

TTNP : 4.61 (-3.76%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, SPTN, TTNP on Behalf of Shareholders

NEW YORK , July 29, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SPTN : 26.90 (+1.66%)
TTNP : 4.61 (-3.76%)
BASE : 24.51 (+0.04%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of TTNP, BASE, SPTN, and CFSB

NEW YORK , July 28, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered...

SPTN : 26.90 (+1.66%)
TTNP : 4.61 (-3.76%)
CFSB : 14.25 (unch)
BASE : 24.51 (+0.04%)
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TCBC, CIO, TTNP, and VBTX

NEW YORK , July 25, 2025 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered...

TTNP : 4.61 (-3.76%)
TCBC : 20.2000 (-0.44%)
VBTX : 30.26 (+1.00%)
CIO : 6.91 (-0.29%)
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock

TTNP : 4.61 (-3.76%)
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

TTNP : 4.61 (-3.76%)
Titan Pharmaceuticals: Q1 Earnings Snapshot

Titan Pharmaceuticals: Q1 Earnings Snapshot

TTNP : 4.61 (-3.76%)
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

TTNP : 4.61 (-3.76%)

Business Summary

Titan Pharmaceuticals Inc was incorporated in Delaware in February 1992. The Company is a specialty pharmaceutical company developing proprietary therapeutics for the treatment of serious medical disorders. Its product development programs engaged mainly in important pharmaceutical markets with significant...

See More

Key Turning Points

3rd Resistance Point 5.01
2nd Resistance Point 4.90
1st Resistance Point 4.76
Last Price 4.61
1st Support Level 4.51
2nd Support Level 4.40
3rd Support Level 4.26

See More

52-Week High 5.76
Fibonacci 61.8% 4.72
Last Price 4.61
Fibonacci 50% 4.39
Fibonacci 38.2% 4.07
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar